US5962490A
(en)
|
1987-09-25 |
1999-10-05 |
Texas Biotechnology Corporation |
Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
|
US5736509A
(en)
*
|
1990-12-14 |
1998-04-07 |
Texas Biotechnology Corporation |
Cyclic peptide surface feature mimics of endothelin
|
AU4376893A
(en)
*
|
1992-05-19 |
1993-12-13 |
Immunopharmaceutics, Inc. |
Compounds that modulate endothelin activity
|
US5352800A
(en)
*
|
1993-03-11 |
1994-10-04 |
Merck & Co., Inc. |
Process for the production of a novel endothelin antagonist
|
US5767310A
(en)
*
|
1993-03-19 |
1998-06-16 |
Merck & Co., Inc. |
Phenoxyphenylacetic acid derivatives
|
US5401745A
(en)
*
|
1993-03-19 |
1995-03-28 |
Merck & Co., Inc. |
Quinazolinones substituted with phenoxyphenylacetic acid derivatives
|
US5374638A
(en)
*
|
1993-03-19 |
1994-12-20 |
Merck & Co., Inc. |
Six membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives used to treat asthma
|
US5420133A
(en)
*
|
1993-03-19 |
1995-05-30 |
Merck & Co., Inc. |
Quinazolinones substituted with phenoxyphenylacetic acid derivatives
|
US5334598A
(en)
*
|
1993-03-19 |
1994-08-02 |
Merck & Co., Inc. |
Six-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives
|
US5527890A
(en)
*
|
1993-04-16 |
1996-06-18 |
Glycomed Incorporated |
Derivatives of triterpenoid acids and uses thereof
|
CA2121724A1
(en)
|
1993-04-21 |
1994-10-22 |
Toshifumi Watanabe |
Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction
|
US6541498B2
(en)
|
1993-05-20 |
2003-04-01 |
Texas Biotechnology |
Benzenesulfonamides and the use thereof to modulate the activity of endothelin
|
US6342610B2
(en)
|
1993-05-20 |
2002-01-29 |
Texas Biotechnology Corp. |
N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
|
US6613804B2
(en)
|
1993-05-20 |
2003-09-02 |
Encysive Pharmaceuticals, Inc. |
Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
|
US6376523B1
(en)
|
1994-05-20 |
2002-04-23 |
Texas Biotechnology Corporation |
Benzenesulfonamides and the use thereof to modulate the activity of endothelin
|
US6030991A
(en)
*
|
1993-05-20 |
2000-02-29 |
Texas Biotechnology Corp. |
Benzenesulfonamides and the use thereof to modulate the activity of endothelin
|
DK0628569T3
(da)
*
|
1993-06-11 |
1996-09-30 |
Shionogi & Co |
Triterpenderivater og endothelinreceptorantagonister indeholdende samme
|
US5686478A
(en)
*
|
1993-07-20 |
1997-11-11 |
Merck & Co. Inc. |
Endothelin antagonists
|
CN1034334C
(zh)
*
|
1993-08-14 |
1997-03-26 |
贵州省中医研究所 |
齐酞酸钠及其药物组合物
|
US5492917A
(en)
*
|
1993-09-29 |
1996-02-20 |
Merck & Co., Inc. |
Endothelin antagonists incorporating a cyclobutane
|
US5559135A
(en)
*
|
1994-09-14 |
1996-09-24 |
Merck & Co., Inc. |
Endothelin antagonists bearing pyridyl amides
|
US5538991A
(en)
*
|
1994-09-14 |
1996-07-23 |
Merck & Co., Inc. |
Endothelin antagonists bearing 5-membered heterocyclic amides
|
PT838223E
(pt)
*
|
1995-06-02 |
2003-12-31 |
Shionogi & Co |
Inibidor do edema cerebral
|
US5977117A
(en)
*
|
1996-01-05 |
1999-11-02 |
Texas Biotechnology Corporation |
Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
|
US5958905A
(en)
|
1996-03-26 |
1999-09-28 |
Texas Biotechnology Corporation |
Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
|
US5804585A
(en)
|
1996-04-15 |
1998-09-08 |
Texas Biotechnology Corporation |
Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
|
TR200101905T2
(tr)
|
1997-04-28 |
2002-06-21 |
Texas Biotechnology Corporation |
Endotelin ile ilgili hastalıkların tedavisinde kullanılan sülfanoamidler.
|
US5783705A
(en)
|
1997-04-28 |
1998-07-21 |
Texas Biotechnology Corporation |
Process of preparing alkali metal salys of hydrophobic sulfonamides
|
US6326507B1
(en)
|
1998-06-19 |
2001-12-04 |
Trustees Of Dartmouth College |
Therapeutic compounds and methods of use
|
US7566452B1
(en)
|
1999-05-04 |
2009-07-28 |
New York University |
Cancer treatment with endothelin receptor antagonists
|
ATE286051T1
(de)
|
1999-12-31 |
2005-01-15 |
Encysive Pharmaceuticals Inc |
Sulfonamide und ihre derivate, die die aktivität des endothelins modulieren
|
MXPA04008944A
(es)
*
|
2002-03-22 |
2004-11-26 |
Shionogi & Co |
Procedimiento para derivados de triterpeno.
|
US20050175667A1
(en)
*
|
2004-02-10 |
2005-08-11 |
Wenda Carlyle |
Use of endothelin antagonists to prevent restenosis
|
EP1757573A4
(de)
|
2004-05-14 |
2008-05-07 |
Shionogi & Co |
Oxidationsreaktion von alkohol mit wasserstoffperoxid und wolframkatalysator
|
ATE502093T1
(de)
*
|
2004-12-21 |
2011-04-15 |
Dow Global Technologies Inc |
Klebstoffzusammensetzung auf polypropylenbasis
|
US7323476B2
(en)
*
|
2006-03-03 |
2008-01-29 |
Savipu Pharmaceuticals |
Myriceric acid derivatives for the treatment of cancer, cardiovascular and inflammatory diseases
|
WO2007103727A2
(en)
*
|
2006-03-03 |
2007-09-13 |
Savipu Pharmaceuticals |
Triterpene derivatives for the treatment of cancer and inflammatory disease by inhibition of nf-kb
|
US20070207989A1
(en)
*
|
2006-03-03 |
2007-09-06 |
Savipu Pharmaceuticals |
Diterpene derivatives for the treatment of cardiovascular, cancer and inflammatory diseases
|
RU2008136315A
(ru)
*
|
2006-03-13 |
2010-04-20 |
Инсайсив Фармасьютикалз, Инк. (US) |
Композиции ситаксентана натрия
|
WO2007106494A2
(en)
*
|
2006-03-13 |
2007-09-20 |
Encysive Pharmaceuticals, Inc. |
Methods and compositions for treatment of diastolic heart failure
|
US20070243273A1
(en)
*
|
2006-04-12 |
2007-10-18 |
Savipu Pharmaceuticals |
Reduction of the Deleterious Effects of Tobacco Smoking
|
US20080026061A1
(en)
*
|
2006-06-22 |
2008-01-31 |
Reichwein John F |
Crystalline N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-methyl-4.5-(methylenedioxy)phenylacetyl]-thiophene-3-sulfonamide
|
US20080017207A1
(en)
*
|
2006-07-18 |
2008-01-24 |
Savipu Pharmaceuticals |
Reduction of the Deleterious Effects of Tobacco Smoking by the Induction of Phase 2 Enzymes by Nerf2
|
US20080187608A1
(en)
*
|
2007-02-05 |
2008-08-07 |
Savipu Pharmaceuticals |
Enriched fractions from clary sage for the treatment of cancer, cardiovascular and inflammatory diseases
|
US20090022821A1
(en)
*
|
2007-07-17 |
2009-01-22 |
Inderjit Kumar Dev |
Compositions from wax myrtle for the treatment of cancer, cardiovascular and inflammatory diseases
|
CN108434151A
(zh)
|
2008-01-11 |
2018-08-24 |
里亚塔医药公司 |
合成三萜类化合物及用以治病之方法
|
EA022588B1
(ru)
|
2008-04-18 |
2016-01-29 |
Ритэ Фамэсутикл, Инк. |
Антиоксидантные модуляторы воспаления: производные олеанолевой кислоты с насыщением в с-кольце
|
CN103342729B
(zh)
*
|
2013-03-26 |
2016-09-14 |
中国科学院上海药物研究所 |
咖啡酰基取代的五环三萜类衍生物及其用途
|
CA3042123A1
(en)
|
2016-11-08 |
2018-05-17 |
Reata Pharmaceuticals, Inc. |
Methods of treating alport syndrome using bardoxolone methyl or analogs thereof
|
CN111356479A
(zh)
|
2018-01-04 |
2020-06-30 |
安瑞特研究有限公司 |
含有白桦脂醇的桦树皮提取物及其制剂
|